QRx Pharma shareholders to get small slice of $7M class action settlement

Blake O'Connor 2020-08-11 10:18 pm By Cat Fredenburgh

Please login to bookmark

A former QRx Pharma director’s prediction that shareholders would not receive “anything of consequence” from a class action settlement has proven true, with only a small slice of the $7 million settlement expected to go to shareholders.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

For information on rights and reprints, contact subscriptions@lawyerly.com.au